Literature DB >> 922557

Interaction of heparin with canine coagulation proteins: in vivo and in vitro studies.

P A Gentry.   

Abstract

The effects of heparin on the coagulation profile and on specific factor activity in canine plasma have been examined both in vivo and in vitro. The results show that the prolongation of the partial thromboplastin time of plasma produced by heparin is, at least in part, the result of the interaction of heparin with the intrinsic Factors VIII, IX and XI and the inhibition of their procoagulant activity by heparin. A significant correlation was found between the partial thromboplastin time assay and the circulating heparin activity following intravenous administration of heparin to dogs. The results confirm the suitability of the partial thromboplastin time assay for monitoring heparin therapy in the dog.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 922557      PMCID: PMC1277739     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  22 in total

1.  Control of anticoagulant therapy. Progress and problems.

Authors:  A J QUICK
Journal:  Arch Intern Med       Date:  1963-02

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  The Stuart-Prower factor assay and its clinical significance.

Authors:  F BACHMANN; F DUCKERT; F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-05-01

4.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

5.  A colorimetric method for the standardization of heparin preparations.

Authors:  F C Macintosh
Journal:  Biochem J       Date:  1941-07       Impact factor: 3.857

6.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

7.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

8.  Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.

Authors:  E T Yin; S Wessler; P J Stoll
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

9.  Preparation of heparin-linked agarose and its interaction with plasma.

Authors:  I Danishefsky; F Tzeng
Journal:  Thromb Res       Date:  1974-02       Impact factor: 3.944

Review 10.  Heparin and platelet function.

Authors:  M B Zucker
Journal:  Fed Proc       Date:  1977-01
View more
  1 in total

1.  A study of the effect of acute systemic anaphylaxis on blood coagulation and TAME esterase activity in calves.

Authors:  W D Black; P A Gentry
Journal:  Can J Comp Med       Date:  1980-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.